Brokerages expect that RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) will post sales of $7.20 million for the current quarter, Zacks reports. Three analysts have made estimates for RVL Pharmaceuticals’ earnings, with estimates ranging from $5.50 million to $10.50 million. RVL Pharmaceuticals reported sales of $23.88 million in the same quarter last year, which would […]
Analysts forecast that RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) will announce earnings per share (EPS) of ($0.25) for the current quarter, according to Zacks. Three analysts have issued estimates for RVL Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.26) and the highest estimate coming in at ($0.24). RVL Pharmaceuticals reported earnings […]
Wall Street analysts expect RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) to post sales of $7.20 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for RVL Pharmaceuticals’ earnings, with estimates ranging from $5.50 million to $10.50 million. RVL Pharmaceuticals posted sales of $23.88 million in the same quarter last […]
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Equities researchers at Cantor Fitzgerald lowered their FY2022 EPS estimates for RVL Pharmaceuticals in a report issued on Thursday, March 31st. Cantor Fitzgerald analyst L. Chen now forecasts that the company will earn ($0.90) per share for the year, down from their prior estimate of ($0.85). Separately, […]
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Investment analysts at Truist Financial upped their FY2026 earnings per share (EPS) estimates for shares of RVL Pharmaceuticals in a report released on Thursday, March 31st. Truist Financial analyst G. Fraser now forecasts that the company will post earnings of $0.57 per share for the year, up […]